BioTechniques is a peer-reviewed, open-access journal dedicated to publishing original laboratory methods, related technical and software tools, and methods-oriented review articles that are of broad interest to professional life scientists, as well as to scientists from other disciplines (e.g., chemistry, physics, computer science, plant and agricultural science and climate science) interested in life science applications for their technologies.
Since 1983, BioTechniques has been a leading peer-reviewed journal for methods-related research. The journal considers:
Reports describing innovative new methods, platforms and software, substantive modifications to existing methods, or innovative applications of existing methods, techniques & tools to new models or scientific questions
Descriptions of technical tools that facilitate the design or performance of experiments or data analysis, such as software and simple laboratory devices
Surveys of technical approaches related to broad fields of research
Reviews discussing advancements in techniques and methods related to broad fields of research
Letters to the Editor and Expert Opinions highlighting interesting observations or cautionary tales concerning experimental design, methodology or analysis
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Michelle S. Itano, University of North Carolina at Chapel Hill (NC, USA)
Editorial Board:
Richard J. Ablin, University of Arizona (AZ, USA) Elinne Becket, California State University San Marcos (CA, USA) Bill L. Brizzard, Brizzard Consulting LLC. (IN, USA) Bruce Budowle, University of North Texas Health Science Center (TX, USA) Piotr Chomczynski, Molecular Research Center (OH, USA) Beth Cimini, Broad Institute of MIT and Harvard (MA, USA) Rita Colwell, University of Maryland (MD, USA) Jeffrey Felton,Western University of Health Sciences (CA, USA) Andrew P French, University of Nottingham (UK) Michel Goedert, MRC Laboratory of Molecular Biology (Cambridge, UK) Peter Greshoff, University of Queensland St Lucia (Brisbane, Australia) Yoshihide Hayashizaki, RIKEN Preventive Medicine and Diagnosis Innovation Program (Japan) Jörg Hoheisel, Deutsches Krebsforschungszentrum (German Cancer Research Center, Heidelberg, Germany) Leroy Hood, Institute for Systems Biology (WA, USA) Shenglin Huang, Fudan University (China) DeLaine Larson, University of California, San Fransisco (CA, USA) Peter Oefner, University of Regensburg (Germany) Steve Paddock, Howard Hughes Medical Institute (WI, USA) Scott D. Patterson, Gilead Sciences (CA, USA) Leonard F. Peruski, Centers for Disease Control and Prevention (GA) & Indiana University School of Medicine, Northwest Center (both USA) George Poste, Arizona State University (AZ, USA) Kwok Pui-Yan, Institute of Biomedical Sciences Academia Sinica (Taiwan) John Quackenbush, Harvard School of Public Health (MA, USA) Joshua Rappoport, Executive Director of Research Infrastructure, Boston College (MA, USA) Barton Slatko, New England Biolabs (MA, USA) Mathias Uhlen, Royal Institute of Technology (Stockholm, Sweeden) Timothy Veenstra, Maranatha Baptist University (WI, USA) Kent Vrana, Penn State College of Medicine (PA, USA) Jennifer Waters, University of North Carolina at Chapel Hill (NC, USA) Micheal Weiner, AxioMx (CT, USA)
Open access
BioTechniques is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![We want to be a resource for your research: Honorbridge]({"type":"image" , "src" : "/sda/112424/JournalAd-leaderboard-ibtn-honorbridge.jpg"})
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![QR code for Honorbridge. Scan the QR code or visit https://partners.honorbridge.org/research/ .]({"type":"image" , "src" : "/sda/112426/JournalAd-mpu-ibtn-honorbridge.jpg"})
![QR code for Honorbridge: We might have what your research needs. Click the QR code or visit https://partners.honorbridge.org/research/ to learn more.]({"type":"image" , "src" : "/sda/112425/JournalAd-skyscraper-ibtn-honorbridge.jpg"})